Quantitative structure-activity relationship studies on some series of calcium channel blockers

Molecular Diversity

Volumn 8, Issue 4, 2004, Pages 357-363

  Gupta, S P ^a   Veerman, Anupriya ^a   Bagaria, Priyanka ^a  

^a BIRLA INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

Author keywords

calcium channel blockers; dihydropyrimidine analogs; quantitative structure activity relationship

Indexed keywords

1,4 DIHYDROPYRIDINE; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; PYRIMIDINE DERIVATIVE; RECEPTOR;

ARTICLE; CONFORMATION; HYDROGEN BOND; MOLECULE; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; SUBSTITUTION REACTION;

ANIMALS; AORTA; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; DIHYDROPYRIDINES; HYDROGEN BONDING; INHIBITORY CONCENTRATION 50; MODELS, CHEMICAL; POTASSIUM; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; RABBITS;

EID: 8544261098     PISSN: 13811991     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:MODI.0000047521.70687.52     Document Type: Article

References (19)

1. Goodfraind, T., Miller, R., and Wibo, M., Calcium antagonism and calcium entry blockade, Pharmacol. Rev., 38 (1986) 321-416.
2. Belleman, P. (Ed.) Innovative Approaches in Drug Research, Elsevier, Amsterdam, 1986, pp. 23-46.
3. Fossheim, R., Svarteng, K., Mostad, A., Romming, C., Shefter, E. and Triggle, D. J., Crystal structures and pharmacological activity of calcium channel antagonists: 2,6-dimethyt-3,5-dicarbomethoxy-4-(unsubstituted, 3-methyl-, 4-methyl-, 3-nitro-, 4-nitro-, and 2,4-dinitrophenyl)-1,4- dihydropyridine, J. Med. Chem., 25 (1982) 126-131.
4. Fossheim, R., Crystal structure of the dihydropyridine calcium antagonist felodipine. Dihydropyridine binding prerequisites assessed from crystallographic data, J. Med. Chem., 29 (1986) 305-307.
5. Arrowsmith, J.E., Campbell, S.F., Cross, P.E., Stubbs, J.K., Burgess, R.A., Gardiner, D.G. and Blackburn, K.J., Long-acting dihydropyridine calcium antagonists. 1,2-Alkoxymethyl derivatives incorporating basic substituents, J. Med. Chem., 29 (1986) 1696-1702.
6. Langs, D.A. and Triggle, D.J., Conformational features of calcium channel agonist and antagonist analogs of nifedipine, Mol. Pharmacol., 27 (1985) 544-548.
7. Atwal, K.S., Rovnyak, G.C., Schwartz, J., Moreland, S., Hedberg, A., Gougoutas, J.Z., Malley, M.F. and Floyd, D.M., Dihydropyrimidine calcium channel blockers: 2-heterosubstituted 4-aryl-1 ,4-dihydro-6-methyl-5- pyrimidinecarboxylic acid esters as potent mimics of dihydropyridines, J. Med. Chem., 33 (1990) 1510-1515.
8. Atwal, K.S., Rovnyak, G.C., Kimball, S.D., Floyd, D.M., Moreland, S., Swanson, B.N., Gougoutas, J.Z., Schwartz, J., Smillie, K.M. and Malley, M.F., Dihydropyrimidine calcium channel blockers. II. 3-Suhstituted-4-aryl-1,4- diliydro-6-methyl-5-pyrimidinecarboxylic acid esters as potent mimics of dihydropyridines, J. Med. Chem., 33 (1990) 2629-2635.
9. Atwal, K.S., Swanson, B.N., Unger, S.E., Floyd, D.M., Moreland, S., Hedberg, A. and O'Reilly, B.C., Dihydropyrimidine calcium channel blockers. 3. 3-carbamoyl-4-aryl-1,2,3,4-tetrahydro-6-methyl-5-pyrimidinecarboxylic acid esters as orally effective antihypertensive agents, J. Med. Chem., 34 (1991) 806-811.
10. Rovnyak, G.C., Atwal, K.S., Hedberg, A., Kimball, S.D., Moreland, S., Gougoutas, J.Z., O'Reilly, B.C., Schwartz, J. and Malley, M.F., Dihydropyrimidine calcium channel blockers. 4. Basic 3-substituted-4-aryl-1,4- dihydropyrimidine-5-carboxylic acid esters. Potent antihypertensive agents, J. Med. Chem., 35 (1992) 3254-3263.
11. Hansch, C. and Leo, A. (Eds.) Substituents Constants for Correlation Analysis in Chemistry and Biology, Wiley, New York, 1979.
12. Kier, L.B. and Hall, L.H. (Eds.) Molecular Connectivity in Chemistry and Drug Research, Academic Press, New York, 1976.
13. Kier, L.B. and Hall, L.H., General definition of valence delta values for molecular connectivity, J. Pharm. Sci., 72 (1983) 1170-1173.
14. Triggle, A.M., Shefter, E. and Triggle, D.J., Crystal structures of calcium channel antagonists: 2,6-dimethyl-3, 5-dicarbomethoxy4-[2-nitro-, 3-cyano-, 4-(dimethylamino)-, and 2,3,4,5,6-pentafluorophenyl]-1.4- dihydropyridine, J. Med. Chem., 23 (1980) 1442-1445.
15. Fossheim, R., Svarteng, K., Mostad, A., Romming, C., Shefter, E. and Triggle, D.J., Crystal structures and pharmacological activity of calcium channel antagonists: 2,6-dimethyl-3,5-dicarbomethoxy-4-(unsubstituted, 3-methyl-, 4-methyl-, 3-nitro-, 4-nitro-, and 2,4-dinitropltenyl)-1,4- dihydropyridine, J. Med. Chem., 25 (1982) 126-131.
16. Baldwin, J.J., Claremon, D.A., Lumma, P.K., McClure, E., Rosenthal, S.A., Linquist, R.J., Faison, E.P., Kaczorowski, G.J., Trumble, M.J. and Smith, G.M., Diethyl 3,6-dihydro-2,4-dimethyl-2,6-methano-1,3-benzothiazocine-5,11- dicarboxylates as calcium entry antagonists: New conformationally restrained analogs of Hantzsch 1,4-dihydropyridines related to nitrendipine as probes for receptor-site conformation, J. Med. Chem., 30 (1987) 690-695.
17. Coburn, R.A., Wierzba, M., Suto, M.J., Solo, A.J., Triggle, A.M. and Triggle, D.J., 1,4-Dihydropyridine antagonist activities at the calcium channel: A quantitative structure-activity relationship approach, J. Med. Chem., 31 (1988) 2103-2107.
18. Viswanadhan, V.N., Mueller, G.A., Basak, S.C. and Weinstein, J.N., Comparison of a neural net-based QSAR algorithm (PCANN) with hologram- and multiple linear regression-based QSAR approaches: Application to 1,4-dihydropyridine-based calcium channel antagonists, J. Chem. Inf. Comput. Sci., 41 (2001) 505-511.
19. Gupta, S.P., Mathur, A.N., Nagappa, A.N., Kumar, D. and Kumaran, S., A quantitative structure-activity relationship study on a novel class of calcium entry blockers: 1-[{4-(aminoalkoxy)phenyl} sulphonyl]indolizines, Eur. J. Med. Chem., 38 (2003) 867-873.